Search

everythinglearnresearchcommunity

for

Search:↓

Environmental factors at different levels control hair stem cell activity, which could lead to new hair growth and alopecia treatments.

Scalp seborrheic dermatitis is a common skin condition linked to oil production and bacteria, with specific diagnostic features and treatments like antifungals and corticosteroids.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

The guide explains how to study human skin fat cells and their tissue, aiming to improve research and medical treatments.

Caspases do more than kill cells; they also help in cell growth and disease, and targeting them could lead to new treatments.

The gene Foxn1 is important for hair growth, and understanding it may lead to new alopecia treatments.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

Scarring alopecia affects different hair follicle stem cells than nonscarring alopecia, and the infundibular region could be a new treatment target.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Women with hair loss often have deficiencies in iron, vitamins, minerals, and lower thyroid function, suggesting the need for nutritional and hormonal treatment.

Patients with acne and insulin resistance have different blood metabolites compared to those with only acne, which could help in diagnosis and treatment.

A man's rare adrenal tumor caused feminization and white hair, was removed surgically, and improved after treatment.

The document concludes that understanding nail anatomy is key for diagnosing nail diseases, early signs of nail melanoma may allow for less aggressive treatment, and specific genetic mutations are important in thyroid cancer prognosis and treatment.

Anti-angiogenic therapy can help treat cancer but may cause resistance and side effects, so alternative methods are being explored.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

New nanoparticles deliver plant extracts to hair follicles to treat conditions like hair loss and acne.

Dupilumab improves eczema in Netherton Syndrome but not ichthyosis linearis circumflexa.

Nanoformulated plant compounds show promise for treating PCOS but need more testing and validation.

A new CBD topical formulation may effectively and safely treat alopecia.

Ablative CO2 laser resurfacing tightens skin by promoting collagen and new cell growth.

Ablative CO2 laser resurfacing tightens skin by destroying and regenerating skin layers.

Men's hair loss is caused by hormones and genes, and can be treated with medication and surgery, while graying is due to aging and has no prevention except dyeing.

Low-dose metformin may help hair regrowth and reduce inflammation in CCCA.

The nano-carrier makes etoposide safer and more effective against lung cancer.

Better supportive care is needed to manage chemotherapy side effects.

The document concludes that more research is needed to create specific drugs for treating male pattern baldness.